Advisory Services Network’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $266 | Buy |
+19
| New | +$256 | ﹤0.01% | 4521 |
|
|
2025
Q4 | – | Sell |
-19
| Closed | -$223 | – | 1987 |
|
|
2025
Q3 | $223 | Buy |
+19
| New | +$223 | ﹤0.01% | 4196 |
|
|
2024
Q1 | – | Sell |
-46
| Closed | -$1.02K | – | 1615 |
|
|
2023
Q4 | $1.02K | Buy |
+46
| New | +$950 | ﹤0.01% | 3528 |
|
|
2023
Q2 | – | Sell |
-64
| Closed | -$1.9K | – | 1599 |
|
|
2023
Q1 | $1.9K | Sell |
64
-58
| -48% | -$1.68K | ﹤0.01% | 3441 |
|
|
2022
Q4 | $3.3K | Buy |
+122
| New | +$2.98K | ﹤0.01% | 3267 |
|
|
2021
Q3 | – | Sell |
-730
| Closed | -$27K | – | 1523 |
|
|
2021
Q2 | $27K | Sell |
730
-4,122
| -85% | -$170K | ﹤0.01% | 2329 |
|
|
2021
Q1 | $212K | Sell |
4,852
-310
| -6% | -$14.5K | 0.01% | 1158 |
|
|
2020
Q4 | $237K | Sell |
5,162
-161
| -3% | -$6.7K | 0.01% | 1000 |
|
|
2020
Q3 | $176K | Sell |
5,323
-2,012
| -27% | -$64.3K | 0.01% | 1022 |
|
|
2020
Q2 | $215K | Sell |
7,335
-897
| -11% | -$26K | 0.01% | 916 |
|
|
2020
Q1 | $222K | Buy |
8,232
+3,503
| +74% | +$105K | 0.01% | 779 |
|
|
2019
Q4 | $159K | Buy |
4,729
+3,526
| +293% | +$128K | 0.01% | 973 |
|
|
2019
Q3 | $53K | Hold |
1,203
| – | – | ﹤0.01% | 1335 |
|
|
2019
Q2 | $53K | Buy |
1,203
+342
| +40% | +$14.6K | ﹤0.01% | 1333 |
|
|
2019
Q1 | $37K | Sell |
861
-65
| -7% | -$2.91K | ﹤0.01% | 1352 |
|
|
2018
Q4 | $41K | Sell |
926
-75
| -7% | -$3.93K | ﹤0.01% | 1213 |
|
|
2018
Q3 | $69K | Sell |
1,001
-553
| -36% | -$35.6K | 0.01% | 1114 |
|
|
2018
Q2 | $89K | Hold |
1,554
| – | – | 0.01% | 995 |
|
|
2018
Q1 | $72K | Buy |
1,554
+417
| +37% | +$19.8K | 0.01% | 1165 |
|
|
2017
Q4 | $53K | Buy |
1,137
+156
| +16% | +$7.17K | ﹤0.01% | 1240 |
|
|
2017
Q3 | $44K | Sell |
981
-200
| -17% | -$8.53K | 0.01% | 1139 |
|
|
2017
Q2 | $46K | Buy |
1,181
+200
| +20% | +$7.56K | 0.01% | 1072 |
|
|
2017
Q1 | $37K | Buy |
+981
| New | +$38.2K | 0.01% | 1070 |
|
|
2016
Q3 | $36K | Buy |
1,046
+90
| +9% | +$3.15K | 0.01% | 958 |
|
|
2016
Q2 | $31K | Buy |
956
+10
| +1% | +$306 | 0.01% | 911 |
|
|
2016
Q1 | $27K | Sell |
946
-30
| -3% | -$799 | 0.01% | 842 |
|
|
2015
Q4 | $33K | Sell |
976
-1,047
| -52% | -$32.6K | 0.01% | 681 |
|
|
2015
Q3 | $58K | Buy |
2,023
+814
| +67% | +$28.4K | 0.02% | 501 |
|
|
2015
Q2 | $48K | Buy |
1,209
+446
| +58% | +$20K | 0.01% | 511 |
|
|
2015
Q1 | $37K | Buy |
+763
| New | +$35.3K | 0.01% | 566 |
|
Other funds holding AVNS
AC
VCM
VPM
Advisory Services Network's AVNS Position: Q1 2026 in Review
Advisory Services Network opened a new position in Avanos Medical (AVNS) in Q1 2026: 19 shares worth $266. The stake represents ﹤0.01% of the portfolio and ranks #4521 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in AVNS as recently as Q3 2025.
Advisory Services Network first reported a position in AVNS in Q1 2015 and has held it in 30 quarters since. The position peaked at $237K in Q4 2020. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Advisory Services Network held 19 shares of Avanos Medical worth $266 as of Q1 2026.
- Avanos Medical was a new Advisory Services Network position in Q1 2026.
- Avanos Medical made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4521 holding.
- Advisory Services Network first reported a position in Avanos Medical in Q1 2015 and has held it in 30 quarters since.
- Advisory Services Network's Avanos Medical position peaked at $237K in Q4 2020.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.